Literature DB >> 2643593

Low dose total body irradiation: a potent anti-retroviral agent in vivo.

R N Shen1, N B Hornback, L Lu, L T Chen, Z Brahmi, H E Broxmeyer.   

Abstract

Immunosuppression characterizes many human diseases including leukemia and AIDS. Friend virus (FV)-induced murine leukemia is a useful model for studying both malignancy and immunosuppression. In a previous series of experiments, we have demonstrated that untreated FV-infected mice died within 40 days post-infection, whereas infected mice given 150 cGy total body irradiation (TBI) on days 5 and 12 exhibited long-term survival. In this report, we show that no leukemic cells or type C virus particles are found in the spleens of mice treated with TBI. In addition, both NK activity as well as bone marrow cell's proliferative responses to PHA and Con A were fully restored. This treatment produces long term control of FV-induced murine leukemia, and thus might have relevance for the treatment of a number of immunosuppressive diseases including AIDS.

Entities:  

Mesh:

Year:  1989        PMID: 2643593     DOI: 10.1016/0360-3016(89)90024-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Potential treatment of inflammatory and proliferative diseases by ultra-low doses of ionizing radiations.

Authors:  Charles L Sanders
Journal:  Dose Response       Date:  2012-10-09       Impact factor: 2.658

2.  Roentgen therapy for infections: an historical review.

Authors:  L B Berk; P J Hodes
Journal:  Yale J Biol Med       Date:  1991 Mar-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.